Skip to content

Women's Health Summit

An overview of minimally invasive embolization treatment for uterine fibroids, adenomyosus, and PCS

Nov 2, 2024 | 8:30 – 11:30 am CST

Saturday, Nov 2, 2024 | 8:30 - 11:30 am CST

Women's Health Summit

Minimally invasive treatments are increasingly replacing invasive surgical procedures, which is certainly also reflected in Women’s Health. Women are increasingly demanding the most elegant possible solution to their problem, a short-term, mild procedure with a quick recovery. Embolization meets this requirement.

Embolization as a treatment for abdominal complaints in women has proven to be a safe and effective treatment, but is nevertheless insufficiently known and insufficiently applied in many medical centers. The clinical success of embolization treatment is high in women with specific complaints due to uterine disease (fibroid and/or adenomyosis) and pathological para-uterine pelvic vasculature, like pelvic congestion syndrome (PCS). It therefore deserves extra attention.

Interventional radiology is the specialty par excellence, in which minimally invasive treatment through embolization is gaining ground compared to invasive surgical procedures. This should also apply to optimal personal patient care for women. The aim of the summit is to provide you a detailed overview of minimally invasive embolization treatment for uterine fibroids, adenomyosus, and PCS; the indications, the different approaches, techniques, available materials and clinical follow-up results.

Women's Health

program

Session 1: Fibroid and Adenomyosis

  • UAE for adenomyosis: how to adjust my technique
  • UAE for adenomyosis: long-term results (QUESTA trial)
  • Resorbable particles in UFE – The Japanese experience
  • Can we use resorbable microspheres for UFE – The South Korean experience
  • Review of evidence for pregnancy after UFE
  • Post Partum Bleeding (PPB): How to quickly determine the proper treatment strategy and prevent failure lurking?
  • Panel Discussion

Varian Industry Session: Expanding UFE in underserved communities

Session 2: Pelvic Congestion Syndrome (PCS) and AVMs

  • Embolization for PCS; Anatomy, patient selection, and how to deal with May-Thurner and Nut-Cracker syndromes
  • Embolization for PCS: Coils, Glue, sclerosant, EVOH based agents: how to choose
  • Uterine AVMs how to classify, how to treat
  • Case 1 – Resorbables in South-Korea for UFE/ADM.
  • Case 2 – Post Partum Bleeding: A difficult and stressful case.
  • Case 3 – PCS: How I do it in Egypt.
  • Case 4 – Challenging case of PCS embolisation.
  • Case 5 – A complicated case of AVM embolisation.
  • Panel Discussion

REGISTER TO ATTEND

Faculty

Jafar Golzarian

Dr. Jafar Golzarian

North Star Vascular & Interventional | University of Minnesota

Marc Sapoval

Pr. Marc Sapoval

Université de paris/ Hopital Européen Georges Pompidou

Paul Lohle

Dr. Paul Lohle

Elisabeth TweeSteden Hospital

Man-Deuk Kim

Dr. Man-Deuk Kim

The Severance Hospital of the Yonsei University Health System

Keigo Osuga

Dr. Keigo Osuga

Osaka Medical and Pharmaceutical Universiity

Dr. Meriem Koual

Hôpital Européen Georges-Pompidou

Joo-Young Chun

Dr. Joo-Young Chun

St George's University Hospitals NHS Foundation Trust

Dr. Gloria Salazar

Dr. Gloria Salazar

UNC School of Medicine

Geert Maleux

Dr. Geert Maleaux

KU LEUVEN

Pierre-Antoine BARRAL

Dr. Pierre-Antoine BARRAL

Hopitaux de Marseille

Dr. Rana Khafagy

Ain Shams University Hospitals

Janice Newsome

Dr. Janice Newsome

Emory University School of Medicine

Contact

GEST Education

The GEST Group has developed premiere events including the annual GEST conference, focused topic meetings and summits where physicians come to learn from other physicians in the field of embolization.
 
 

Thank you to the following companies for supporting this educational event through sponsorship or educational grants.